• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用计算机模拟潜力预测、验证新型化合物抗血管生成机制并阐释其作用机制:湿实验室数据与计算机模拟数据的比较相关性

Exploitation of in silico potential in prediction, validation and elucidation of mechanism of anti-angiogenesis by novel compounds: comparative correlation between wet lab and in silico data.

作者信息

Arif Jamal M, Siddiqui M Haris, Akhtar Salman, Al-Sagair Othman A

机构信息

Department of Biochemistry, College of Medicine, University of Hail, P.O. Box 2440, Hail, KSA.

出版信息

Int J Bioinform Res Appl. 2013;9(4):336-48. doi: 10.1504/IJBRA.2013.054697.

DOI:10.1504/IJBRA.2013.054697
PMID:23797993
Abstract

This study describes in silico validation of the wet lab data from aeroplysinin-1, curcumin and halofuginone using Autodock Tools 4.0. The inhibition patterns of the vascular endothelial cell differentiation and capillary tube formation mediated by anti-angiogenic growth factors from these test compounds were found quite comparable with the in silico results using angiogenic targets (EFGR, bFGF and VEGFR-1). Successful validation of the wet lab results of the selected angiogenic targets by in silico method has led to exploit the hidden potential of in silico tools in preliminary screening of the unknown compounds for anti-angiogenic potential in a cost-effective manner.

摘要

本研究描述了使用Autodock Tools 4.0对来自aero plysin - 1、姜黄素和常山酮的湿实验室数据进行计算机模拟验证。发现这些测试化合物中抗血管生成生长因子介导的血管内皮细胞分化和毛细血管管形成的抑制模式与使用血管生成靶点(EFGR、bFGF和VEGFR - 1)的计算机模拟结果相当。通过计算机模拟方法成功验证所选血管生成靶点的湿实验室结果,从而能够以具有成本效益的方式利用计算机模拟工具在初步筛选未知化合物抗血管生成潜力方面的潜在价值。

相似文献

1
Exploitation of in silico potential in prediction, validation and elucidation of mechanism of anti-angiogenesis by novel compounds: comparative correlation between wet lab and in silico data.利用计算机模拟潜力预测、验证新型化合物抗血管生成机制并阐释其作用机制:湿实验室数据与计算机模拟数据的比较相关性
Int J Bioinform Res Appl. 2013;9(4):336-48. doi: 10.1504/IJBRA.2013.054697.
2
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.常山酮:血管生成进程关键步骤的强效抑制剂。
FASEB J. 2000 Dec;14(15):2477-85. doi: 10.1096/fj.00-0292com.
3
Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.血管内皮生长因子(VEGF)受体-2拮抗剂在体内和体外均可抑制VEGF和碱性成纤维细胞生长因子诱导的血管生成。
J Pharmacol Exp Ther. 2001 Dec;299(3):1073-85.
4
Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge.从海洋海绵中分离出的一种溴化化合物——柳珊瑚素-1的抗血管生成活性。
FASEB J. 2002 Feb;16(2):261-3. doi: 10.1096/fj.01-0427fje. Epub 2001 Dec 28.
5
Antiangiogenic versus cytotoxic activity in analogues of aeroplysinin-1.刺参素 -1类似物的抗血管生成与细胞毒性活性
Bioorg Med Chem. 2007 Aug 1;15(15):5300-15. doi: 10.1016/j.bmc.2007.05.011. Epub 2007 May 6.
6
Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.罗多斯汀是一种蛇毒解整合素,它可抑制碱性成纤维细胞生长因子引发的血管生成,并通过选择性阻断内皮细胞的α(v)β(3)来抑制肿瘤生长。
Mol Pharmacol. 2001 May;59(5):1333-42. doi: 10.1124/mol.59.5.1333.
7
Identification of novel angiogenesis inhibitors.新型血管生成抑制剂的鉴定。
Bioorg Med Chem Lett. 2005 Sep 15;15(18):4125-9. doi: 10.1016/j.bmcl.2005.06.001.
8
Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.肾上腺髓质素刺激培养的人血管内皮细胞的血管生成反应:血管内皮生长因子受体2的参与
Peptides. 2008 Nov;29(11):2013-23. doi: 10.1016/j.peptides.2008.07.009. Epub 2008 Jul 23.
9
Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.倍半萜烯的抗血管生成活性;FGF-2诱导血管生成的天然产物抑制剂
Angiogenesis. 2008;11(3):245-56. doi: 10.1007/s10456-008-9108-2. Epub 2008 Mar 11.
10
In-silico fragment-based identification of novel angiogenesis inhibitors.
Bioorg Med Chem Lett. 2007 Aug 15;17(16):4551-6. doi: 10.1016/j.bmcl.2007.05.104. Epub 2007 Jun 15.

引用本文的文献

1
Virtual screening,docking and molecular dynamics simulation of selected phytochemical compounds bound to receptor tyrosine kinases:A correlative anti angiogenic study.与受体酪氨酸激酶结合的选定植物化学化合物的虚拟筛选、对接和分子动力学模拟:一项相关的抗血管生成研究。
Bioinformation. 2019 Sep 30;15(9):613-620. doi: 10.6026/97320630015613. eCollection 2019.
2
In-silico designing of a potent analogue against HIV-1 Nef protein and protease by predicting its interaction network with host cell proteins.通过预测HIV-1 Nef蛋白和蛋白酶与宿主细胞蛋白的相互作用网络,对一种有效的类似物进行计算机辅助设计。
J Pharm Bioallied Sci. 2013 Jan;5(1):66-73. doi: 10.4103/0975-7406.106572.